J. Krocker

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Sherko Kümmel, J. Krocker, A. Kohls et al. · British Journal of Cancer · 2006 · 53 citations · Full text

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Peter Schmid, J. Krocker, C. Jehn et al. · Annals of Oncology · 2005 · 38 citations

Breast Oncology, Early Breast Cancer, Medicine +9

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

Peter A. Fasching, Sebastian M. Jud, Maik Hauschild et al. · BMC Cancer · 2014 · 25 citations · Full text

Detection ofBRCA1 andBRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure

E. Spitzer, Mohammad Reza Abbaszadegan, Frank Schmidt et al. · International Journal of Cancer · 2000 · 20 citations

Breast Oncology, Oncology, Somatic Variant +12

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Sherko Küemmel, J. Krocker, A. Kohls et al. · Journal of Clinical Oncology · 2004 · 19 citations

Breast Oncology, Elderly Patients, Cancer Management +19